Would you like to receive the latest vacancies in your e-mail box? Create a job alert based on your keyword(s) and preferences.
Clinical Development Scientist
For the CellPoint/Galapagos organisation in Leiden/NL, we are looking for a (Sr.) Clinical Development Scientist
As (Sr.) Clinical Development Scientist, you join our growing Clinical Development team located in the Leiden Bio Science Park. A highly interesting position for a scientist driven to use methodological, analytical and scientific expertise to develop smart study designs in different phases of clinical development.
You play a key role in study design, protocol writing, statistical analysis plan development, interpreting study results for data-driven decision making, and writing of clinical study reports. To co-drive innovation, you also keep up to date with conference updates and literature publications. Furthermore, you enjoy working in close collaboration with Clinical Operations, Data Management, Statistics and Translational Science, as well as other stakeholders, to ensure accurate and relevant data is collected with a solid study set up, enabling best in class analysis.
As an experienced professional with a complete understanding of the field of clinical research you become instrumental in the development of our clinical program with novel CAR-T therapies in multiple (hemato-)oncological indications towards clinical trials and regulatory approval. By doing so, you contribute directly to the initial treatment of cancer patients, and the generation of data to make these CAR-Ts widely available.
The (Sr.) Scientist Clinical Development reports to the Head of Clinical Development.
• Master’s degree or PhD in (Bio-)Medical/life sciences
• Hemato-oncology background is strongly preferred
• 3 or more years of relevant experience in a similar role is required
• Solid understanding of phase I-III drug development
• Excellent team player, able to deliver in a demanding environment
• Good organizational skills
• Excellent writing and communication skills both towards team members within the company as towards external contacts
• Enthusiastic to work on-site in our beautiful offices in Leiden
• Self-driven and can-do mindset, without compromising quality and compliance
• You have good interpersonal skills and written and spoken fluency in English
You will be part of a fast growing and amazing company. As a ‘make-it-happener’ you will get all the support you need to make your job successful. At CellPoint/Galapagos we aim to recruit the best people, who stand out among their peers, with integrity and excellent interpersonal and organisational skills. Our employees are the strength behind Galapagos/CellPoint, you will join a highly motivated team, eager to maintain our leading position and to achieve breakthroughs in pharmaceutical research. New team members have the opportunity to actively shape their position and contribute to our mission. Galapagos/CellPoint offers a competitive remuneration package and a dynamic work environment. Flexible working hours can be discussed.
We are Galapagos : together we can make it happen…!
Pleased to meet you, we are CellPoint, a Galapagos company. We’re a dynamic fast growing Biotech company in the business of changing lives.
Galapagos’ mission is to make a lasting positive contribution to society through discovery of innovative therapies for diseases with large unmet medical need. Galapagos seeks to develop a robust portfolio of therapies that have the potential to revolutionize existing treatment paradigms. The company’s ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines to improve patients’ lives. Galapagos’ historic focus on developing first-in-class medicines based on the discovery of novel targets in inflammation and fibrosis has led to the successful launch of our first medicine in rheumatoid arthritis in 2020 and in ulcerative colitis in 2021. The pivotal study in Crohn’s Disease is fully recruited and we expect topline data and potential approval in this new indication in a couple of years.
Galapagos is now entering an exciting new chapter to expand and diversify its pipeline for the future, starting with oncology, specifically CAR-T cell-therapy, a transformative treatment of different types of cancer. Through the combined acquisitions of CellPoint and AboundBio, we are propelling ourselves into next-generation cell therapies. CellPoint brings a novel, decentralized point-of-care cell therapy manufacturing model, which has the potential to offer efficient, 7-day time to treatment and avoids complex logistics, resulting in potential better patient outcomes and broader access. For more information, please visit www.cellpoint.bio.